XGES.L vs. GNOG.L
Compare and contrast key facts about Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L).
XGES.L and GNOG.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XGES.L is a passively managed fund by DWS that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Jul 12, 2022. GNOG.L is a passively managed fund by Global X that tracks the performance of the MSCI World/Health Care NR USD. It was launched on Nov 2, 2021. Both XGES.L and GNOG.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
XGES.L vs. GNOG.L - Performance Comparison
Loading graphics...
XGES.L vs. GNOG.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XGES.L Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -3.32% | 11.22% | -1.38% | -7.92% | -8.46% |
GNOG.L Global X Genomics & Biotechnology UCITS ETF | -1.16% | 12.03% | -16.98% | -11.35% | -15.08% |
Returns By Period
In the year-to-date period, XGES.L achieves a -3.32% return, which is significantly lower than GNOG.L's -1.16% return.
XGES.L
- 1D
- 2.27%
- 1M
- -2.38%
- YTD
- -3.32%
- 6M
- 4.92%
- 1Y
- 16.23%
- 3Y*
- 0.30%
- 5Y*
- —
- 10Y*
- —
GNOG.L
- 1D
- 3.29%
- 1M
- -4.36%
- YTD
- -1.16%
- 6M
- 14.72%
- 1Y
- 37.00%
- 3Y*
- -4.91%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XGES.L vs. GNOG.L - Expense Ratio Comparison
XGES.L has a 0.35% expense ratio, which is lower than GNOG.L's 0.50% expense ratio.
Return for Risk
XGES.L vs. GNOG.L — Risk / Return Rank
XGES.L
GNOG.L
XGES.L vs. GNOG.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) and Global X Genomics & Biotechnology UCITS ETF (GNOG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XGES.L | GNOG.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.83 | 1.23 | -0.41 |
Sortino ratioReturn per unit of downside risk | 1.24 | 1.79 | -0.55 |
Omega ratioGain probability vs. loss probability | 1.15 | 1.22 | -0.07 |
Calmar ratioReturn relative to maximum drawdown | 1.25 | 2.22 | -0.97 |
Martin ratioReturn relative to average drawdown | 3.79 | 6.61 | -2.82 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XGES.L | GNOG.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.83 | 1.23 | -0.41 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.16 | -0.45 | +0.28 |
Correlation
The correlation between XGES.L and GNOG.L is 0.86, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
XGES.L vs. GNOG.L - Dividend Comparison
Neither XGES.L nor GNOG.L has paid dividends to shareholders.
Drawdowns
XGES.L vs. GNOG.L - Drawdown Comparison
The maximum XGES.L drawdown since its inception was -35.79%, smaller than the maximum GNOG.L drawdown of -67.50%. Use the drawdown chart below to compare losses from any high point for XGES.L and GNOG.L.
Loading graphics...
Drawdown Indicators
| XGES.L | GNOG.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.79% | -67.50% | +31.71% |
Max Drawdown (1Y)Largest decline over 1 year | -13.81% | -17.16% | +3.35% |
Current DrawdownCurrent decline from peak | -14.80% | -48.74% | +33.94% |
Average DrawdownAverage peak-to-trough decline | -18.03% | -44.07% | +26.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.55% | 5.75% | -1.20% |
Volatility
XGES.L vs. GNOG.L - Volatility Comparison
The current volatility for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) is 6.30%, while Global X Genomics & Biotechnology UCITS ETF (GNOG.L) has a volatility of 9.63%. This indicates that XGES.L experiences smaller price fluctuations and is considered to be less risky than GNOG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XGES.L | GNOG.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.30% | 9.63% | -3.33% |
Volatility (6M)Calculated over the trailing 6-month period | 12.59% | 21.09% | -8.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.58% | 29.88% | -10.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.12% | 31.32% | -13.20% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.12% | 31.32% | -13.20% |